Uncovering Modifier Genes of X-Linked Alport Syndrome Using a Novel Multiparent Mouse Model.


Journal

Journal of the American Society of Nephrology : JASN
ISSN: 1533-3450
Titre abrégé: J Am Soc Nephrol
Pays: United States
ID NLM: 9013836

Informations de publication

Date de publication:
08 2021
Historique:
received: 03 06 2020
accepted: 27 03 2021
pubmed: 29 5 2021
medline: 21 10 2021
entrez: 28 5 2021
Statut: ppublish

Résumé

Mutations in We created a cohort of genetically diverse XLAS male and female mice using the Diversity Outbred mouse resource and measured albuminuria, GFR, and gene expression. Using a quantitative trait locus approach, we mapped modifier genes that can best explain the underlying phenotypic variation measured in our diverse population. Genetic analysis identified several loci associated with the variation in albuminuria and GFR, including a locus on the X chromosome associated with X inactivation and a locus on chromosome 2 containing With this novel approach, we emulated the variability in the severity of kidney phenotypes found in human patients with Alport Syndrome through albuminuria and GFR measurements. This approach can identify modifier genes in kidney disease that can be used as novel therapeutic targets.

Sections du résumé

BACKGROUND
Mutations in
METHODS
We created a cohort of genetically diverse XLAS male and female mice using the Diversity Outbred mouse resource and measured albuminuria, GFR, and gene expression. Using a quantitative trait locus approach, we mapped modifier genes that can best explain the underlying phenotypic variation measured in our diverse population.
RESULTS
Genetic analysis identified several loci associated with the variation in albuminuria and GFR, including a locus on the X chromosome associated with X inactivation and a locus on chromosome 2 containing
CONCLUSION
With this novel approach, we emulated the variability in the severity of kidney phenotypes found in human patients with Alport Syndrome through albuminuria and GFR measurements. This approach can identify modifier genes in kidney disease that can be used as novel therapeutic targets.

Identifiants

pubmed: 34045313
pii: 00001751-202108000-00018
doi: 10.1681/ASN.2020060777
pmc: PMC8455275
doi:

Substances chimiques

Col4a5 protein, mouse 0
Collagen Type IV 0
Formins 0
Creatinine AYI8EX34EU

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1961-1973

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 202860/Z/16/Z
Pays : United Kingdom

Informations de copyright

Copyright © 2021 by the American Society of Nephrology.

Références

Sci Rep. 2016 Oct 11;6:35068
pubmed: 27725732
G3 (Bethesda). 2014 Sep 18;4(9):1623-33
pubmed: 25237114
Nat Genet. 2013 May;45(5):531-6
pubmed: 23542698
PLoS One. 2008 Jun 18;3(6):e2497
pubmed: 18560567
Physiol Genomics. 2018 Aug 1;50(8):543-552
pubmed: 29652635
J Am Soc Nephrol. 2015 Dec;26(12):3021-34
pubmed: 25896609
Kidney Int. 2014 Jun;85(6):1461-8
pubmed: 24522496
Pediatr Nephrol. 2012 Jan;27(1):41-6
pubmed: 21380623
Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E668-E675
pubmed: 29282321
Eur J Hum Genet. 2012 Jun;20(6):
pubmed: 22166944
Nephrol Dial Transplant. 2010 Mar;25(3):764-9
pubmed: 19854849
J Am Soc Nephrol. 2013 Feb;24(3):364-75
pubmed: 23349312
G3 (Bethesda). 2015 Dec 18;6(2):263-79
pubmed: 26684931
Clin Exp Nephrol. 2020 Aug;24(8):1-9
pubmed: 32277301
Matrix Biol. 2017 Jan;57-58:45-54
pubmed: 27576055
Bioinformatics. 2018 Jul 1;34(13):2177-2184
pubmed: 29444201
PLoS Genet. 2013;9(10):e1003853
pubmed: 24098153
Pediatr Nephrol. 2013 Jan;28(1):5-11
pubmed: 22461141
Nat Rev Genet. 2001 Mar;2(3):165-74
pubmed: 11256068
Nat Rev Nephrol. 2013 Mar;9(3):170-8
pubmed: 23165304
Nat Commun. 2015 Mar 10;6:6496
pubmed: 25754093
Am J Pathol. 2002 Feb;160(2):721-30
pubmed: 11839593
J Am Soc Nephrol. 2004 Jun;15(6):1466-74
pubmed: 15153557
Hum Mol Genet. 2009 Jul 1;18(13):2472-82
pubmed: 19383632
J Am Soc Nephrol. 2005 Apr;16(4):977-85
pubmed: 15716328
J Am Soc Nephrol. 2003 Oct;14(10):2603-10
pubmed: 14514738
Ren Fail. 2017 Nov;39(1):290-293
pubmed: 27917694

Auteurs

Valerie Wright (V)

The Jackson Laboratory, Bar Harbor, Maine.

Bernard Davenport (B)

Wellcome Centre for Cell-Matrix Research, Division of Cell-Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.

Daniel M Gatti (DM)

The Jackson Laboratory, Bar Harbor, Maine.

Susan M Sheehan (SM)

The Jackson Laboratory, Bar Harbor, Maine.

Kelsey Letson (K)

The Jackson Laboratory, Bar Harbor, Maine.

Holly S Savage (HS)

The Jackson Laboratory, Bar Harbor, Maine.

Rachel Lennon (R)

Wellcome Centre for Cell-Matrix Research, Division of Cell-Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.

Ron Korstanje (R)

The Jackson Laboratory, Bar Harbor, Maine Ron.Korstanje@jax.org.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH